InsidersTradesSigma
Total declarations
Company
▲ Purchases (19 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Young Caroline, Director. Officer active across 1 companies, notably Cumberland Pharmaceuticals INC. Cumulatively, 22 filings have been logged. Total volume traded: €792. The latest transaction was filed on 1 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations22 total
€4825 shares@ €1.92410.0001% mcap0.6% of flow
Common Stock
SEC:0001209191-22-040108:0·
Ideal exit: 26 Feb 2023 (T+270)
€4720 shares@ €2.33130.0001% mcap0.5% of flow
Common Stock
SEC:0001209191-22-036008:0·
Ideal exit: 27 Jan 2023 (T+270)
€4819 shares@ €2.50440.0001% mcap0.6% of flow
Common Stock
SEC:0001209191-22-027651:0·
Ideal exit: 9 Jan 2023 (T+270)
€2,3611,000 shares@ €2.36110.0029% mcap27.6% of flow
Common Stock
SEC:0001209191-22-026152:0·
€6618 shares@ €3.65390.0001% mcap2.2% of flow
Common Stock
SEC:0001209191-22-002462·
Ideal exit: 28 Aug 2022 (T+270)
€6618 shares@ €3.65390.0001% mcap0.8% of flow
Common Stock
SEC:0001209191-22-002462:0·
Ideal exit: 28 Aug 2022 (T+270)
€3515 shares@ €2.31040.0000% mcap1.1% of flow
Common Stock
SEC:0001209191-21-067892·
Ideal exit: 29 Jul 2022 (T+270)
€3515 shares@ €2.31040.0000% mcap0.4% of flow
Common Stock
SEC:0001209191-21-067892:0·
Ideal exit: 29 Jul 2022 (T+270)
€3515 shares@ €2.32410.0000% mcap1.2% of flow
Common Stock
SEC:0001209191-21-063225·
Ideal exit: 28 Jun 2022 (T+270)
€3515 shares@ €2.32410.0000% mcap0.4% of flow
Common Stock
SEC:0001209191-21-063225:0·
Ideal exit: 28 Jun 2022 (T+270)
€3615 shares@ €2.43220.0000% mcap1.2% of flow
Common Stock
SEC:0001209191-21-058521·
Ideal exit: 29 May 2022 (T+270)
€3615 shares@ €2.43220.0000% mcap0.4% of flow
Common Stock
SEC:0001209191-21-058521:0·
Ideal exit: 29 May 2022 (T+270)
€3715 shares@ €2.45650.0000% mcap1.2% of flow
Common Stock
SEC:0001209191-21-055492·
Ideal exit: 28 Mar 2022 (T+270)
€4215 shares@ €2.81270.0001% mcap1.4% of flow
Common Stock
SEC:0001209191-21-055494·
Ideal exit: 29 Apr 2022 (T+270)
€3815 shares@ €2.5310.0000% mcap1.3% of flow
Common Stock
SEC:0001209191-21-055488·
Ideal exit: 11 Jan 2022 (T+270)
€3615 shares@ €2.4030.0000% mcap1.2% of flow
Common Stock
SEC:0001209191-21-055490·
Ideal exit: 22 Feb 2022 (T+270)
€3715 shares@ €2.45650.0000% mcap0.4% of flow
Common Stock
SEC:0001209191-21-055492:0·
Ideal exit: 28 Mar 2022 (T+270)
€4215 shares@ €2.81270.0001% mcap0.5% of flow
Common Stock
SEC:0001209191-21-055494:0·
Ideal exit: 29 Apr 2022 (T+270)
€3815 shares@ €2.5310.0000% mcap0.4% of flow
Common Stock
SEC:0001209191-21-055488:0·
Ideal exit: 11 Jan 2022 (T+270)
€3615 shares@ €2.4030.0000% mcap0.4% of flow
Common Stock
SEC:0001209191-21-055490:0·
Ideal exit: 22 Feb 2022 (T+270)
€2,7061,000 shares@ €2.70550.0033% mcap31.6% of flow
Common Stock
SEC:0001209191-21-039938:0·
€2,7061,000 shares@ €2.70550.0033% mcap89.3% of flow
Common Stock
SEC:0001209191-21-039938·
22 of 22 declarations
About Young Caroline
Caroline Young is associated with CUMBERLAND PHARMACEUTICALS INC.
